Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

The RNA AL136131.3 slows down hair growth and speeds up hair loss by affecting sugar breakdown in hair follicles.

Ginseng extracts protect brain cells and reduce damage in diabetic rats.

Akt2 and SGK3 are both important for normal hair growth and development.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Dapagliflozin improved blood sugar control in a man with Werner syndrome without side effects.

The FDA approved a new Pfizer drug for hair loss in teens.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Applying a specific inhibitor lightens skin and hair color.

OR-101 shows promise for treating alopecia areata by improving hair growth.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

The research found a way to develop hair growth materials by targeting a specific signaling pathway.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Ginsenoside CK, found in Panax ginseng, can prevent hair loss by controlling certain growth pathways and promoting hair follicle development.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

GPIGS peptide increases thick hair growth in balding Japanese men.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Cilostazol helps hair grow by making hair root cells grow faster and changing growth factor levels.

Not having the gene PLAAT3 leads to fat loss, high insulin resistance, and abnormal fat levels in the blood due to a disruption in fat cell development and function.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Entospletinib effectively prevents eye and skin GVHD in mice.

STEAP3 protein might help treat hair loss, but more testing is needed.

Targeting the HEDGEHOG-GLI1 pathway could help treat keloids.

A pancreatic tumor caused high glucagon levels and symptoms, but treatment reduced glucagon and shrank liver tumors.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.